Screener
Rhythm Pharmaceuticals, Inc. RYTM Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Revenues: | ||
| Product revenue, net | $60,112 | $37,718 |
| License revenue | — | (5,014) |
| Total revenues | 60,112 | 32,704 |
| Costs and expenses: | ||
| Cost of sales | 7,157 | 3,648 |
| Research and development | 41,725 | 36,973 |
| Selling, general, and administrative | 63,591 | 39,087 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s total revenue?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported total revenue of $60.11M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s total revenue changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s total revenue increased by 83.8% year-over-year, from $32.7M to $60.11M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s total revenue has grown at a 178.5% compound annual growth rate (CAGR), from $3.15M to $189.76M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude